United States Healthcare Equipment & Supplies

Track

STRATA Skin Sciences Inc (SSKN)

Track

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: SSKN Exchange: NAS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Rubinstein Samuel

2 purchases — total 7,028 USD

Buy 18 Nov 2025

Value US$4,218,468.44 | Price 299.95 | Shares 56,284

Buy 18 Nov 2025

Value US$1,753,258.24 | Price 178.22 | Shares 9,309

Rubinstein Samuel

3 sales — total 18,804 USD

Sale 17 Nov 2025

Value US$2,951,067.18 | Price 471.40 | Shares 77,297

Sale 17 Nov 2025

Value US$2,981,191.51 | Price 163.99 | Shares 57,390

Sale 17 Nov 2025

Value US$7,260.00 | Price 1.32 | Shares 5,500

Geiger Uri

1 purchase — total 723,999 USD

Buy 15 Jul 2024

Value US$723,999.22 | Price 3.14 | Shares 230,573

Rafaeli Dolev

Chief Executive Officer

1 purchase — total 59,974 USD

Buy 15 Jul 2024

Value US$59,974.00 | Price 3.14 | Shares 19,100

Accelmed Partners, L.P.

1 purchase — total 723,999 USD

Buy 15 Jul 2024

Value US$723,999.22 | Price 3.14 | Shares 230,573

Gov Shmuel

COO

4 purchases — total 8,956 USD

Buy 1 Dec 2023

Value US$2,256.00 | Price 0.47 | Shares 4,800

Buy 1 Dec 2023

Value US$138.00 | Price 0.46 | Shares 300

Buy 1 Dec 2023

Value US$252.90 | Price 0.45 | Shares 562

Buy 1 Dec 2023

Value US$6,308.72 | Price 0.44 | Shares 14,338

Rubinstein Samuel

1 sale — total 320 USD

Sale 16 Nov 2023

Value US$320.00 | Price 0.32 | Shares 1,000

22NW, LP

1 purchase — total 1,023,072 USD

Buy 16 Aug 2023

Value US$1,023,072.22 | Price 0.55 | Shares 1,853,056

Lesovitz Christopher

Chief Financial Officer

2 purchases — total 10,153 USD

Buy 10 Aug 2023

Value US$6,650.00 | Price 0.67 | Shares 10,000

Buy 10 Aug 2023

Value US$3,502.68 | Price 0.68 | Shares 5,151

Moccia Robert Joseph

Chief Executive Officer

1 purchase — total 28,308 USD

Buy 10 Aug 2023

Value US$28,308.00 | Price 0.67 | Shares 42,000

Rubinstein Samuel

1 purchase — total 1,092 USD

Buy 15 Jun 2022

Value US$1,092.00 | Price 1.04 | Shares 1,050

Lesovitz Christopher

Chief Financial Officer

1 purchase — total 25,907 USD

Buy 12 May 2022

Value US$25,906.72 | Price 1.12 | Shares 23,131

Humphries William D.

1 purchase — total 29,385 USD

Buy 25 Mar 2022

Value US$29,384.52 | Price 1.73 | Shares 16,950

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-11-18	2025-11-18	B Purchase	2.3 Rubinstein Samuel Non-Executive Director	56,284 -14.2% 299.95 US$4,218,468	56,284 -14.2%	299.95	US$4,218,468
2025-11-18	2025-11-18	B Purchase	2.3 Rubinstein Samuel Non-Executive Director	9,309 -30.6% 178.22 US$1,753,258	9,309 -30.6%	178.22	US$1,753,258
2025-11-18	2025-11-17	S Sale	2.3 Rubinstein Samuel Non-Executive Director	77,297 +26.4% 471.40 US$2,951,067	77,297 +26.4%	471.40	US$2,951,067
2025-11-18	2025-11-17	S Sale	2.3 Rubinstein Samuel Non-Executive Director	7,200 -58.3% 1.34 US$9,648	7,200 -58.3%	1.34	US$9,648
2025-11-18	2025-11-17	S Sale	2.3 Rubinstein Samuel Non-Executive Director	5,500 -30.8% 1.32 US$7,260	5,500 -30.8%	1.32	US$7,260
2024-07-17	2024-07-15	B Purchase	0.9 Geiger Uri Non-Executive Director Large shareholder	230,573 +19.0% 3.14 US$723,999	230,573 +19.0%	3.14	US$723,999
2024-07-17	2024-07-15	B Purchase	0.9 Rafaeli Dolev Chief Executive Officer Executive Director	19,100 +15.4% 3.14 US$59,974	19,100 +15.4%	3.14	US$59,974
2024-07-17	2024-07-15	B Purchase	0.9 Accelmed Partners, L.P. Large shareholder	230,573 +19.0% 3.14 US$723,999	230,573 +19.0%	3.14	US$723,999
2023-12-05	2023-12-01	B Purchase	2.4 Gov Shmuel COO Officer	4,800 +31.6% 0.47 US$2,256	4,800 +31.6%	0.47	US$2,256
2023-12-05	2023-12-01	B Purchase	2.4 Gov Shmuel COO Officer	300 +2.0% 0.46 US$138	300 +2.0%	0.46	US$138
2023-12-05	2023-12-01	B Purchase	2.4 Gov Shmuel COO Officer	562 +3.9% 0.45 US$253	562 +3.9%	0.45	US$253
2023-12-05	2023-12-01	B Purchase	2.4 Gov Shmuel COO Officer	14,338 +inf% 0.44 US$6,309	14,338 +inf%	0.44	US$6,309
2023-11-20	2023-11-16	S Sale	2.3 Rubinstein Samuel Non-Executive Director	1,000 -0.6% 0.32 US$320	1,000 -0.6%	0.32	US$320
2023-08-18	2023-08-16	B Purchase	2.8 22NW, LP Large shareholder	1,853,056 +52.7% 0.55 US$1,023,072	1,853,056 +52.7%	0.55	US$1,023,072
2023-08-11	2023-08-10	B Purchase	1.3 Lesovitz Christopher Chief Financial Officer Officer	10,000 +35.4% 0.67 US$6,650	10,000 +35.4%	0.67	US$6,650
2023-08-11	2023-08-10	B Purchase	1.3 Lesovitz Christopher Chief Financial Officer Officer	5,151 +22.3% 0.68 US$3,503	5,151 +22.3%	0.68	US$3,503
2023-08-11	2023-08-10	B Purchase	1.1 Moccia Robert Joseph Chief Executive Officer Executive Director	42,000 +21.7% 0.67 US$28,308	42,000 +21.7%	0.67	US$28,308
2022-06-15	2022-06-15	B Purchase	2.3 Rubinstein Samuel Non-Executive Director	1,050 +1.0% 1.04 US$1,092	1,050 +1.0%	1.04	US$1,092
2022-05-13	2022-05-12	B Purchase	1.3 Lesovitz Christopher Chief Financial Officer Officer	23,131 +inf% 1.12 US$25,907	23,131 +inf%	1.12	US$25,907
2022-03-28	2022-03-25	B Purchase	2.3 Humphries William D. Non-Executive Director	16,950 +3.6% 1.73 US$29,385	16,950 +3.6%	1.73	US$29,385